Mangalam Organics Limited

rs,

40 Date: January 28, 2023 BSE Limited Listing & Compliance Department Phiroze Jeejeebhoy Towers, Dalal Street, Fort Mumbai – 400001. Scrip Code: 514418 The National Stock Exchange of India Limi

10,000 MT

focus on Brands ‘Mangalam’ and ‘Campure’ Successfully completed the expansion to manufacture 10,000 MT of Camphor 5 Our Business Segments B2B - Terpene Revenue break-up • Camphor: Religious use, h

80%

try, Leather tanning • • Isobornyl Acetate: Fragrance and flavor Isoborneol: Fragrance and flavor 80% Terpene Operations B2B - Synthetic Resin • Terpene Phenolic Resin - Adhesives • Alkyl Phenolic

4%

astic compounds for road marking, hot melts and glues susceptible to pressure, insulation finishes 4% Synthetic Resin Operations B2C - Retail Operations • CamPure - Homecare and personal care prod

10%

ucts based on Camphor • Mangalam - Camphor tablets for pious uses • Private Labelling Initiatives 10% In FY21 16% Retail Operations in FY22 6 Our Business Model Chemistry Capabilities B2C Re

16%

Camphor • Mangalam - Camphor tablets for pious uses • Private Labelling Initiatives 10% In FY21 16% Retail Operations in FY22 6 Our Business Model Chemistry Capabilities B2C Retailing Exper

rs 8

sin Camphor| Dipentene | Sodium Acetate Terpene Phenolic Resin | Alkyl Phenolic Resin | Rosin Esters 8 Our Product Portfolio – B2C Business-to-Consumer CamPure - Homecare and personal care products bas

45%

ns 10 Financials FY22 Consolidated Financial Performance Revenues (Rs. Crs) EBITDA (Rs. Crs) +45% 490.6 338.2 -29% 127.8 91.0 PAT (Rs. Crs) -37% 84.6 53.7 FY21 FY22 FY21 FY22 FY21 FY

29%

FY22 Consolidated Financial Performance Revenues (Rs. Crs) EBITDA (Rs. Crs) +45% 490.6 338.2 -29% 127.8 91.0 PAT (Rs. Crs) -37% 84.6 53.7 FY21 FY22 FY21 FY22 FY21 FY22 EBITDA Margin (%

37%

mance Revenues (Rs. Crs) EBITDA (Rs. Crs) +45% 490.6 338.2 -29% 127.8 91.0 PAT (Rs. Crs) -37% 84.6 53.7 FY21 FY22 FY21 FY22 FY21 FY22 EBITDA Margin (%) 1930 bps 37.8% PAT Margin (%)

1930 bps

27.8 91.0 PAT (Rs. Crs) -37% 84.6 53.7 FY21 FY22 FY21 FY22 FY21 FY22 EBITDA Margin (%) 1930 bps 37.8% PAT Margin (%) 1410 bps 25.0% 18.5% 10.9% • • • • Revenue growth of 45% in FY22 vs

37.8%

PAT (Rs. Crs) -37% 84.6 53.7 FY21 FY22 FY21 FY22 FY21 FY22 EBITDA Margin (%) 1930 bps 37.8% PAT Margin (%) 1410 bps 25.0% 18.5% 10.9% • • • • Revenue growth of 45% in FY22 vs FY21.